Most Read Articles
Roshini Claire Anthony, 23 Aug 2019

Individuals with type 2 diabetes mellitus (T2D) may be at risk of developing gastric cancer even after receiving Helicobacter pylori (H. pylori) eradication therapy, demonstrated a study from Hong Kong.

21 hours ago
New drug application approved by US FDA as of 01 - 15 September 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Amitriptyline helps improve psychological stress, sleep in functional dyspepsia

19 Dec 2017

In patients with functional dyspepsia (FD), amitriptyline may yield improvements in psychological stress and sleep, albeit modestly, according to posthoc data from a clinical trial.

Researchers analysed data from a multicentre, double-blind trial evaluating the efficacy of antidepressants on FD symptoms. In the trial, 292 patients had been randomly assigned to groups given 50 mg amitriptyline, 10 mg escitalopram, or placebo for 12 weeks.

All patients completed at baseline and 12 weeks the following psychological questionnaires: Symptom Check List 90, Symptom Somatic Checklist, Hospital Anxiety Depression Scale, Profile of Mood States, State Trait Anxiety Inventory, and Pittsburgh Sleep Quality Index.

Baseline scores for the psychological and sleep measures did not differ among groups. Likewise, scores after 12 weeks were similar among groups.

Mean global Pittsburgh Sleep Quality Index scores indicated poor sleep quality in all groups at both timepoints. Antidepressants affected sleep duration scores such that patients given amitriptyline had better scores than patients who received placebo or escitalopram (p=0.019).

In all groups, treatment responders achieved reductions in anxiety and improvements in some sleep components.

The present data suggest that while amitriptyline has been shown to induce reductions in symptoms of FD, such reductions may not involve improvements in psychological stress, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 23 Aug 2019

Individuals with type 2 diabetes mellitus (T2D) may be at risk of developing gastric cancer even after receiving Helicobacter pylori (H. pylori) eradication therapy, demonstrated a study from Hong Kong.

21 hours ago
New drug application approved by US FDA as of 01 - 15 September 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.